Widschwendter M - Search Results

1

hCDC4 gene mutations in endometrial cancer.

Spruck CH, Strohmaier H, Sangfelt O, Müller HM, Hubalek M, Müller-Holzner E, Marth C, Widschwendter M, Reed SI. Spruck CH, et al. Among authors: widschwendter m. Cancer Res. 2002 Aug 15;62(16):4535-9. Cancer Res. 2002. PMID: 12183400

2

Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.

Widschwendter M, Daxenbichler G, Dapunt O, Marth C. Widschwendter M, et al. Cancer Res. 1995 May 15;55(10):2135-9. Cancer Res. 1995. PMID: 7743514

3

Mechanism of synergistic action of all-trans- or 9-cis-retinoic acid and interferons in breast cancer cells.

Marth C, Widschwendter M, Daxenbichler G. Marth C, et al. Among authors: widschwendter m. J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):123-6. doi: 10.1016/0960-0760(93)90065-5. J Steroid Biochem Mol Biol. 1993. PMID: 8274426

4

Effects of Taxol on choriocarcinoma cells.

Marth C, Lang T, Widschwendter M, Müller-Holzner E, Daxenbichler G. Marth C, et al. Among authors: widschwendter m. Am J Obstet Gynecol. 1995 Dec;173(6):1835-42. doi: 10.1016/0002-9378(95)90437-9. Am J Obstet Gynecol. 1995. PMID: 8610772

5

Sensitivity of breast and ovarian cancer cells for interferons (IFNs) and retinoids.

Daxenbichler G, Widschwendter M, Marth C. Daxenbichler G, et al. Among authors: widschwendter m. Ann N Y Acad Sci. 1996 Apr 30;784:294-303. doi: 10.1111/j.1749-6632.1996.tb16244.x. Ann N Y Acad Sci. 1996. PMID: 8651578 No abstract available.

6

Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.

Marth C, Zeimet AG, Widschwendter M, Ludescher C, Kaern J, Tropé C, Gastl G, Daxenbichler G, Dapunt O. Marth C, et al. Among authors: widschwendter m. Cancer Res. 1997 Sep 1;57(17):3818-22. Cancer Res. 1997. PMID: 9288793

7

Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.

Widschwendter M, Berger J, Daxenbichler G, Müller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG. Widschwendter M, et al. Among authors: widschwendter a. Cancer Res. 1997 Oct 1;57(19):4158-61. Cancer Res. 1997. PMID: 9331065

8

High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.

Zeimet AG, Widschwendter M, Uhl-Steidl M, Müller-Holzner E, Daxenbichler G, Marth C, Dapunt O. Zeimet AG, et al. Among authors: widschwendter m. Br J Cancer. 1997;76(12):1646-51. doi: 10.1038/bjc.1997.611. Br J Cancer. 1997. PMID: 9413956 Free PMC article.

9

Regulation of CA 125 expression in cultured human carcinoma cells.

Marth C, Zeimet AG, Widschwendter M, Daxenbichler G. Marth C, et al. Among authors: widschwendter m. Int J Biol Markers. 1998 Oct-Dec;13(4):207-9. Int J Biol Markers. 1998. PMID: 10228902 Review.

10

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

Abendstein B, Marth C, Müller-Holzner E, Widschwendter M, Daxenbichler G, Zeimet AG. Abendstein B, et al. Among authors: widschwendter m. Cancer. 2000 Mar 15;88(6):1432-7. doi: 10.1002/(sici)1097-0142(20000315)88:6<1432::aid-cncr22>3.0.co;2-8. Cancer. 2000. PMID: 10717627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters